Oculis Holding AG Ordinary shares
Biotechnology
Healthcare
OCS
48.26 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
17.70
52 week high
22.91
high
18.00
52 week low
0.00
low
17.24
growth
47.92 %
previous Close
17.73
P/E ratio
market cap
908 M
div yield
0
usd
Jun 2025
qoq
revenue
0.00 %
net incoming
0.00 %
eps
0.00 %
28.99 %
eps surprise
-12.75 %
net profit margin
0.00 %
0.00 %
operating incoming
0.00 %
net change in cash
0.00 %
cash on hand
0.00 %
cost of revenue
0.00 %
top top